Equities research analysts expect Cerner Co. (NASDAQ:CERN) to report earnings of $0.59 per share for the current quarter, Zacks Investment Research reports. Eleven analysts have made estimates for Cerner’s earnings, with estimates ranging from $0.57 to $0.68. Cerner also posted earnings of $0.59 per share during the same quarter last year. The firm is expected to issue its next quarterly earnings report on Thursday, April 26th.
On average, analysts expect that Cerner will report full year earnings of $2.65 per share for the current fiscal year, with EPS estimates ranging from $2.57 to $2.77. For the next financial year, analysts anticipate that the company will post earnings of $2.98 per share, with EPS estimates ranging from $2.85 to $3.20. Zacks’ EPS averages are a mean average based on a survey of sell-side research analysts that follow Cerner.
Cerner (NASDAQ:CERN) last released its quarterly earnings results on Tuesday, February 6th. The company reported $0.58 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.61 by ($0.03). Cerner had a net margin of 16.86% and a return on equity of 16.82%. The firm had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter in the previous year, the business earned $0.61 EPS. The company’s revenue for the quarter was up 4.5% on a year-over-year basis.
A number of brokerages have recently issued reports on CERN. Cantor Fitzgerald reduced their price objective on Cerner from $83.00 to $80.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 7th. Piper Jaffray Companies reissued a “buy” rating and issued a $70.00 target price on shares of Cerner in a research note on Thursday, November 30th. Citigroup began coverage on Cerner in a research note on Thursday, January 4th. They issued a “neutral” rating on the stock. BidaskClub cut Cerner from a “buy” rating to a “hold” rating in a research note on Friday, December 22nd. Finally, Zacks Investment Research raised Cerner from a “sell” rating to a “hold” rating in a research note on Tuesday, December 26th. One analyst has rated the stock with a sell rating, twelve have given a hold rating and nine have assigned a buy rating to the company. Cerner has a consensus rating of “Hold” and an average target price of $67.50.
In other news, Vice Chairman Clifford W. Illig sold 307,700 shares of Cerner stock in a transaction that occurred on Thursday, March 8th. The shares were sold at an average price of $64.52, for a total transaction of $19,852,804.00. Following the completion of the transaction, the insider now directly owns 1,229,719 shares in the company, valued at $79,341,469.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Jeffrey A. Townsend sold 230,000 shares of Cerner stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $61.94, for a total transaction of $14,246,200.00. The disclosure for this sale can be found here. Insiders have sold 541,800 shares of company stock valued at $34,353,860 over the last quarter. Company insiders own 13.11% of the company’s stock.
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Cedar Hill Associates LLC purchased a new position in Cerner in the 4th quarter worth approximately $200,000. Xact Kapitalforvaltning AB raised its holdings in Cerner by 3.7% in the 4th quarter. Xact Kapitalforvaltning AB now owns 47,338 shares of the company’s stock worth $3,190,000 after acquiring an additional 1,702 shares during the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its holdings in Cerner by 2.0% in the 4th quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 385,067 shares of the company’s stock worth $25,950,000 after acquiring an additional 7,558 shares during the last quarter. We Are One Seven LLC purchased a new position in Cerner in the 4th quarter worth approximately $576,000. Finally, Compagnie Lombard Odier SCmA grew its position in Cerner by 889.5% in the 4th quarter. Compagnie Lombard Odier SCmA now owns 10,885 shares of the company’s stock worth $733,000 after purchasing an additional 9,785 shares during the period. Institutional investors own 78.56% of the company’s stock.
Shares of Cerner (CERN) traded up $0.04 during trading hours on Monday, hitting $62.08. The stock had a trading volume of 185,869 shares, compared to its average volume of 2,439,157. Cerner has a 52-week low of $55.50 and a 52-week high of $73.86. The company has a market capitalization of $20,630.00, a PE ratio of 29.13, a P/E/G ratio of 1.83 and a beta of 0.93. The company has a quick ratio of 2.99, a current ratio of 3.01 and a debt-to-equity ratio of 0.11.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.